TRCT
NBP

Tower Research Capital (TRC)’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Tower Research Capital (TRC)’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.44K Buy
4,326
+1,085
+33% +$2.21K ﹤0.01% 4073
2026
Q1 		$7.97K Buy
3,241
+1,476
+84% +$4.94K ﹤0.01% 3993
2025
Q4 		$7.03K Buy
+1,765
New +$7.81K ﹤0.01% 4038
2024
Q4 		– Sell
-4,015
Closed -$4.98K – 5834
2024
Q3 		$4.98K Buy
+4,015
New +$5.03K ﹤0.01% 4354
2024
Q1 		– Sell
-24,608
Closed -$46.8K – 5993
2023
Q4 		$46.8K Sell
24,608
-3,510
-12% -$5.24K ﹤0.01% 3171
2023
Q3 		$37.1K Buy
28,118
+20,473
+268% +$45K ﹤0.01% 2832
2023
Q2 		$22.9K Buy
7,645
+2,957
+63% +$9.5K ﹤0.01% 3269
2023
Q1 		$16K Sell
4,688
-1,831
-28% -$8.87K ﹤0.01% 3703
2022
Q4 		$27K Sell
6,519
-62,650
-91% -$237K ﹤0.01% 2836
2022
Q3 		$278K Buy
69,169
+67,388
+3,784% +$511K ﹤0.01% 1617
2022
Q2 		$20K Sell
1,781
-3,407
-66% -$40.8K ﹤0.01% 3789
2022
Q1 		$84K Buy
5,188
+4,227
+440% +$108K ﹤0.01% 2341
2021
Q4 		$46K Sell
961
-1,416
-60% -$85K ﹤0.01% 2822
2021
Q3 		$172K Buy
2,377
+1,551
+188% +$112K ﹤0.01% 1950
2021
Q2 		$69K Buy
826
+126
+18% +$8.31K ﹤0.01% 2752
2021
Q1 		$34K Buy
700
+485
+226% +$26.3K ﹤0.01% 3453
2020
Q4 		$10K Buy
+215
New +$8.47K ﹤0.01% 4312

Other funds holding NBP

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
AIHC Capital Management Central $104M AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s NBP Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 33% in Q2 2026, buying an estimated $2.21K and bringing the position to 4,326 shares worth $8.44K. The position accounts for ﹤0.01% of the portfolio, ranked #4073.

Tower Research Capital (TRC) first reported a position in NBP in Q4 2020 and has held it in 17 quarters since. The position peaked at $278K in Q3 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Tower Research Capital (TRC) held 4,326 shares of NovaBridge Biosciences American Depositary Shares worth $8.44K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,085 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $2.21K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4073 holding.
  • Tower Research Capital (TRC) first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s NovaBridge Biosciences American Depositary Shares position peaked at $278K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.